|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4
is a Highly Efficient Radiotherapeutic for Glucagon-Like Peptide-1
Receptor-Targeted Therapy for Insulinoma Clin Cancer Res. 2007 Jun 15;13(12):3696-705.
PMID: 17575235 |
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |